Home   Business   Life Science

Subscribe Now

Life Science




Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

The company has also announced BBI Group as manufacturer for the test it is creating with Cytiva.

1

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

The Waterbeach-based gene editing company says it is encouraged by its prospects for the rest of 2020.


Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

They will also prepare for future pandemics.


NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

The combined company will be headquartered at Babraham Research Campus and in Cambridge, Massachusetts.


AstraZeneca’s new medicines power its growth in first half of year

AstraZeneca’s new medicines power its growth in first half of year

AstraZeneca’s new medicines power its growth in first half of year

The Cambridge-based biopharmaceutical company recorded revenue and profit growth despite the Covid-19 pandemic.


Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

Move will give the Whittlesford-based company access to patient samples.


Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

The group expects to report revenues of £260million and is in the midst of a growth strategy.


AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

The deal surrounds antibody drug conjugate DS-1062, which could redefine treatments in lung, breast and multiple other cancers.


Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

AZD1222 generates both an antibody and T cell response, and appears safe, data shows.


Bit Bio lease means BioMed@Babraham is full after only 12 months

Bit Bio lease means BioMed@Babraham is full after only 12 months

Bit Bio lease means BioMed@Babraham is full after only 12 months

The human synthetic biology pioneer joins PetMedix, Mission Therapeutics and RxCelerate at the site.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More